LEMBO, Serena
 Distribuzione geografica
Continente #
NA - Nord America 6.808
AS - Asia 4.818
EU - Europa 3.629
SA - Sud America 588
AF - Africa 75
OC - Oceania 6
Totale 15.924
Nazione #
US - Stati Uniti d'America 6.724
HK - Hong Kong 2.181
IT - Italia 1.344
FI - Finlandia 1.200
SG - Singapore 1.164
CN - Cina 528
BR - Brasile 437
VN - Vietnam 416
RU - Federazione Russa 249
FR - Francia 145
DE - Germania 123
UA - Ucraina 112
IE - Irlanda 111
KR - Corea 107
SE - Svezia 95
TR - Turchia 92
IN - India 90
AR - Argentina 63
NL - Olanda 53
GB - Regno Unito 47
JP - Giappone 42
BD - Bangladesh 37
MX - Messico 32
CA - Canada 31
AT - Austria 26
EC - Ecuador 24
PL - Polonia 24
IQ - Iraq 23
CO - Colombia 22
ES - Italia 21
ID - Indonesia 21
PK - Pakistan 16
VE - Venezuela 15
ZA - Sudafrica 15
CH - Svizzera 14
MY - Malesia 13
PH - Filippine 13
KE - Kenya 10
PY - Paraguay 10
TN - Tunisia 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
EG - Egitto 9
MA - Marocco 9
LT - Lituania 8
DZ - Algeria 7
JO - Giordania 7
PE - Perù 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
BE - Belgio 6
SA - Arabia Saudita 6
GR - Grecia 5
HR - Croazia 5
IL - Israele 5
BG - Bulgaria 4
BH - Bahrain 4
CL - Cile 4
DK - Danimarca 4
ET - Etiopia 4
JM - Giamaica 4
OM - Oman 4
PA - Panama 4
PS - Palestinian Territory 4
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
GE - Georgia 3
IR - Iran 3
KW - Kuwait 3
LU - Lussemburgo 3
PT - Portogallo 3
RS - Serbia 3
SN - Senegal 3
UY - Uruguay 3
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
HU - Ungheria 2
LB - Libano 2
MK - Macedonia 2
MN - Mongolia 2
MU - Mauritius 2
NI - Nicaragua 2
NP - Nepal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
GL - Groenlandia 1
GY - Guiana 1
HN - Honduras 1
IS - Islanda 1
Totale 15.909
Città #
Dallas 2.898
Hong Kong 2.177
Helsinki 1.180
San Jose 554
Singapore 537
Ann Arbor 465
Chandler 339
Princeton 298
Woodbridge 207
Ashburn 205
Houston 155
Council Bluffs 149
Wilmington 136
Rome 126
The Dalles 122
Ho Chi Minh City 120
Lauterbourg 119
Jacksonville 118
Milan 113
Beijing 107
Dublin 107
Moscow 90
Dong Ket 87
Izmir 78
Naples 69
Hanoi 62
Salerno 51
Andover 50
Munich 49
Nanjing 46
Los Angeles 45
New York 41
Boardman 40
São Paulo 40
Pellezzano 39
Tokyo 37
Amsterdam 27
Bari 25
Nuremberg 25
Seattle 25
Genoa 24
Redwood City 24
Stockholm 24
Hebei 23
Santa Clara 22
Chennai 21
Fairfield 21
Warsaw 21
Frankfurt am Main 20
Orem 20
Columbus 19
Da Nang 18
Rio de Janeiro 18
Shenyang 18
Denver 17
Fisciano 17
Palermo 17
Seoul 17
Brooklyn 16
Changsha 16
London 16
Turin 16
Bologna 15
Haiphong 15
Mumbai 15
Norwalk 15
Curitiba 14
Montreal 14
Turku 14
Boston 12
Pune 12
San Francisco 12
Verona 12
Florence 11
Messina 11
Mexico City 11
Napoli 11
Quito 11
Belo Horizonte 10
Cava de' Tirreni 10
Vienna 10
Baghdad 9
Thái Nguyên 9
Albignasego 8
Atlanta 8
Nanchang 8
Shanghai 8
Tashkent 8
West Jordan 8
Brasília 7
Brno 7
Buenos Aires 7
Istanbul 7
Jiaxing 7
Mercato San Severino 7
Nairobi 7
Santa Venerina 7
Sarno 7
Venice 7
Asti 6
Totale 11.960
Nome #
058 Oxidative stress in atopic dermatitis and cardiovascular disease: urinary biopyrrins as possible biomarker 3.978
Eruzione cutanea dopo vaccino SARS CoV-2 in paziente psoriasico trattato con MTX 788
A Long-Term Real-Life Safety Study of Guselkumab in Psoriasis Patients with Infectious Comorbidities, Malignancies or Heart Disease: The EARLY Study 468
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 439
Automatic psoriasis assessment methods: Current scenario and perspectives from a metrologic point of view 324
Systemic Treatment of Pediatric Psoriasis: A Review 291
Prevalence, Features and Degree of Association of Oral Lesions in COVID-19: A Systematic Review of Systematic Reviews 237
Psoriasi eritrodermica: rapida efficacia di bimekizumab 205
The anti-inflammatory and antioxidant properties of 1,2-decanediol and willow bark extract in lipopolysaccharide-stimulated keratinocytes 171
Anti-inflammatory properties of low and high doxycycline doses: An in vitro study 152
An acute spondyloarthritis during successful treatment with dupilumab for severe atopic dermatitis 147
Phenolics from Castanea sativa leaves and their effects on UVB-induced damage 138
Psoriasi e salute del cavo orale: un nesso da non sottovalutare. I primi risultati di uno studio clinico osservazionale 136
IL-36 cytokines are increased in acne and hidradenitis suppurativa 133
Farsi promotori di salute: “Safe Sun Coast” 132
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 129
Sicurezza ed efficacia di Apremilast in paziente psoriasico oncologico in terapia con pembrolizumab 125
Psoriasis and bone damage: the role of phosphodiesterase 4 in the pro-osteoclastogenic process induced by skin inflammation. 123
Photodermatoses 123
Effectiveness and Tolerability of a Patch Containing Onion Extract and Allantoin for Cesarean Section Scars 120
Understanding the role of haptoglobin in psoriasis: Effects of ultraviolet B 118
Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris 112
Atopic dermatitis: Epidemiology and clinical phenotypes 111
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 109
Nicotinamide downregulates gene expression of interleukin-6, interleukin-10, monocyte chemoattractant protein-1, and tumour necrosis factor-α gene expression in HaCaT keratinocytes after ultraviolet B irradiation 108
The modulatory effect of ellagic acid and rosmarinic acid on ultraviolet-B-induced cytokine/chemokine gene expression in skin keratinocyte (HaCaT) cells 107
Presence of BAG3 protein in serum samples from patients affected by psoriasis 104
Milk thistle and olive extract: old substances with a new mission against sun-induced skin damage 103
Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis 98
Anti-tumor necrosis factor-α therapy in the management of psoriasis and B-chronic lymphocytic leukemia 98
Surprise from skin nodules after travel to South America 97
Fotodermatosi 97
Interleukin-33: increasing role in dermatological conditions 96
Anti-IL-17 therapy rapidly decreases osteoclast activity in psoriatic patients: A novel quality in addition to its efficacy and safety 94
Abnormal isoaspartyl residues in erythrocyte membranes from psoriatic patients 92
Carcinoma basocellulare con invasione perineurale: gestione terapeutica 91
Toilet contact dermatitis 91
A preterm infant with benign neonatal hemangiomatosis and persistent patent ductus arteriosus: A curious comorbidity 89
The effect of visible blue light on the differentiation of dendritic cells in vitro 88
Polymorphic light eruption and skin cancer prevalence: Is one protective against the other? 87
Aberrant gene expression with deficient apoptotic keratinocyte clearance may predispose to polymorphic light eruption 87
A New Light on the Dark DNA Damages 86
Un ingrediente fitoattivo da scarti di Castanea sativa 83
121 Oxidative stress in atopic dermatitis: urinary biopyrrins as possible new biomarker 83
Cancrum oris in a boy with Down syndrome 81
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B 79
Apremilast, NB-UVB e MTX: confronto del profilo di efficacia, di sicurezza e capacità di modulazione dell’infiammazione sistemica nei pazienti psoriasici. Studio osservazionale di coorte prospettico 79
"Pro-osteoclastogenesis march" is induced by cutaneous pro-inflammatory mediators 79
IL-33 is regulated by TNF-α in normal and psoriatic skin 78
"Active" photoprotection: Sunscreens with DNA repair enzymes 78
Confronto del profilo di efficacia, sicurezza e compliance tra Apremilast, NB-UVB e MTX nei pazienti psoriasici: i primi risultati di uno studio osservazionale multicentrico italiano 77
Skin cancer overview. Chapter I: Photodermatoses and skin cancer. 77
Secukinumab e popolazioni speciali: focus su tubercolosi latente ed epatite virale: studio retrospettivo 77
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 76
Oral Lesions and Oral Health-Related Quality of Life in Adult Patients with Psoriasis: A Retrospective Chart Review 75
Paraoxonases and psoriasis: negative imbalance of anti--oxidant endogenous mechanisms 73
Psoriasiform dermatitis during dupilumab treatment in atopic patient resolved after combo-therapy with methotrexate 72
Assessing the beneficial impact of a patient support program in secukinumab-treated patients with psoriasis in italy 69
PDE4 Inhibition Reduced Osteoclast Differentiation in Psoriatic Patients 68
Effects of adalimumab therapy in adult subjects with moderate-to-severe psoriasis on Th17 pathway 68
Hair whitening in a patient with psoriasis during failure of adalimumab treatment reversed by ixekizumab 68
Clinical predictors of psoriatic arthritis and osteoclast differentiation 68
Professional's and non-professional's papular urticaria caused by Scleroderma domesticum 67
null 67
Cutaneous Eruption after SARS-CoV-2 vaccine in psoriatic patient treated with methotrexate 66
null 65
IL-26 in allergic contact dermatitis: Resource in a state of readiness 65
From the skin to the bone: Pro-osteoclastogenesis inflammatory march 65
null 64
Pizza makers' contact dermatitis 64
A severe relapse of pemphigus vulgaris after SARS-CoV-2 vaccination 63
null 63
Psoriasis in melanoma patients: a prospective pilot study 62
Mammalian target of rapamycin in inflammatory skin conditions 62
null 60
Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders 60
Farmaci biologici e small molecules in dermatite atopica: confronto su efficacia e sugli effetti nella gestione del prurito 59
Photosensitivity and cancer immune-targeted therapies 59
null 58
The important role of interdisciplinary collaboration in the management of a melanocytic skin lesion 58
Contact sensitization of children referred to the Dermatology Department of the University Federico II of Naples, Italy: a two-decade years history 57
Polymorphic light eruption: What's new in pathogenesis and management 57
Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study 57
null 55
Crack abuse-induced recalcitrant ulcers 55
Immuno-Pathogenesis of Chronic Inflammatory Skin Diseases: Novel Molecular Targets and Biomarkers 54
null 54
Misurazione dinamica degli inquinanti in pazienti affetti da dermatite atopica 53
Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity 53
null 52
null 52
Sporotrichosis: long-term treatment and follow-up in a diabetic patient from Southern Italy 51
Real-Life Effectiveness and Safety of Guselkumab in Patients with Psoriasis Who Have an Inadequate Response to Ustekinumab: A 3-Year Multicenter Study 50
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study 50
Chromatin assembly factor-1/p60 overexpression: A potential index of psoriasis severity 49
Mechanistic target of rapamycin complex 1 is involved in psoriasis and regulated by anti-TNF-α treatment 49
IL-26: A new actor in allergic contact dermatitis 49
Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world study 48
Dupilumab therapy reduces urinary biopyrrin levels in atopic patients: a new possible biomarker of oxidative status in atopic dermatitis 48
null 48
Totale 14.198
Categoria #
all - tutte 46.765
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.765


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021127 0 0 0 0 0 0 0 0 0 0 20 107
2021/2022485 2 4 3 12 30 5 5 18 56 47 75 228
2022/2023910 89 64 24 114 86 175 6 103 157 15 51 26
2023/2024688 45 80 38 32 48 54 36 44 21 79 61 150
2024/20251.966 95 39 132 157 93 242 229 124 332 120 186 217
2025/202610.247 302 2.108 3.174 449 661 295 922 250 1.448 610 28 0
Totale 16.155